The DOI matches its Crossref record; 87 of the 93 references it cites were found in a registry or an index; 90 of the 150 sources its claims cite were checked for support.
Identification of human gene research articles with wrongly identified nucleotide sequences
Open accessPublished version of a preprint
Abstract
Nucleotide sequence reagents underpin molecular techniques that have been applied across hundreds of thousands of publications. We have previously reported wrongly identified nucleotide sequence reagents in human research publications and described a semi-automated screening tool Seek & Blastn to fact-check their claimed status. We applied Seek & Blastn to screen >11,700 publications across five literature corpora, including all original publications in Gene from 2007 to 2018 and all original open-access publications in Oncology Reports from 2014 to 2018. After manually checking Seek & Blastn outputs for >3,400 human research articles, we identified 712 articles across 78 journals that described at least one wrongly identified nucleotide sequence. Verifying the claimed identities of >13,700 sequences highlighted 1,535 wrongly identified sequences, most of which were claimed targeting reagents for the analysis of 365 human protein-coding genes and 120 non-coding RNAs. The 712 problematic articles have received >17,000 citations, including citations by human clinical trials. Given our estimate that approximately one-quarter of problematic articles may misinform the future development of human therapies, urgent measures are required to address unreliable gene research articles.
Overview
CoChat Summary
TL;DR
Using Seek & Blastn with manual verification, this study screened >11,700 human gene research articles across five corpora and identified 712 problematic articles containing 1,535 wrongly identified nucleotide sequences. These articles span 78 journals, have accumulated >17,000 citations, and almost all remain uncorrected.
Key findings
- S&B screened >11,700 articles, flagged 3,423 for manual verification, and confirmed 712 problematic articles with 1,535 wrongly identified sequences across 31 publishers and 78 journals.
- Problematic article rates were 75/174 (43%) in the SGK corpus, 31/50 (62%) in the miR-145 corpus, 51/100 (51%) in the cisplatin + gemcitabine corpus, 128/742 flagged Gene articles (17%), and 436/1,709 flagged Oncology Reports articles (26%).
- Most incorrect sequences were (RT-)PCR reagents (1,301/1,535, 85%), followed by si/shRNAs (226/1,535, 15%); most problematic articles in targeted and Oncology Reports corpora were from China, often hospital-affiliated.
- The 712 problematic articles had been cited 17,183 times by March 2021; only 2% (11/712) were retracted, three had expressions of concern, and average approximate potential to translate ranged from 15% to 35% across corpora.
Methods
- Semi-automated Seek & Blastn (S&B) extracted nucleotide sequences and text descriptors, used Blastn to predict targeting/non-targeting status, flagged contradictions, and manually verified flagged outputs; >13,700 nucleotide sequences were checked.
- Five corpora were screened: three targeted corpora (SGK articles for 17 human genes; miR-145 articles; cisplatin and gemcitabine articles) and two journal corpora (Gene 2007–2018; open-access Oncology Reports 2014–2018).
- Analyses included country and institutional affiliation, post-publication notices, citation counts, gene knowledge-base indexing, gene2pubmed linkage, Fisher’s exact tests, Mann–Whitney U tests, and approximate potential to translate (APT).
Limitations
- Stated: not all articles in Gene and Oncology Reports were manually verified (10% and 45%, respectively), so some problematic articles may have been missed; Blastn’s low but measurable false-negative rate means some flagged non-targeting reagents could be false positives, though multiple errors per article provide some protection.
- Stated: targeted corpora were derived from search terms and index articles previously associated with problematic articles, mostly from China, so rates may not reflect the wider literature; miR-145 and C+G corpora were not exhaustive, and journal selection may have increased detection of problematic articles from China and hospital-affiliated authors.
- Evident from the text: the study is observational and cannot prove fraud or paper-mill involvement; country and institution associations are descriptive, and reagent errors were not validated by wet-lab experiments.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
42 Valid · 2 Not valid · 6 Not checked · 174 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Experiments that analyse individual genes typically require nucleotide sequence reagents as either targeting and/or control reagents (8, 11).”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Introduction
What the sources say
- Partly supportedcites [8] sourceExperimental — accuracy not yet measured
The Introduction section on single-gene knockdown publications says nucleotide sequence reagents are foundational to gene knockdown studies and describes targeting reagents and non-targeting controls. It does not establish that experiments analysing individual genes generally require such reagents; the cited discussion is specifically about gene knockdown. (LLM, conf=0.84)
- Partly supportedcites [11] sourceExperimental — accuracy not yet measured
The ‘Published nucleotide sequence reagent errors’ section says experiments analysing gene function often employ short DNA or RNA sequences corresponding to genes of interest. The ‘Incorrect non-targeting nucleotide sequence reagents’ section says individual gene knockdowns are typically paired with a non-targeting control. These passages support the use of targeting and control reagents, but not the broader assertion that experiments analysing individual genes typically require them. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“We proposed that the similarities between and errors within SGK articles could reflect the undeclared involvement of organisations such as paper mills (13), which have been alleged to mass-produce fraudulent manuscripts for publication (24, 25).”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Introduction
What the sources say
- Not checked — no full text of the sourcecites [13] source
- Supportedcites [24] source
This source is cited for the statement that paper mills are alleged to mass-produce fraudulent manuscripts, not for the SGK-specific proposal, which the citing sentence attributes to reference 13. The paper’s introductory passage says paper mills allegedly offer fraudulent or fabricated manuscripts, and its opening summary says they likely produce or contribute to large numbers of manuscripts for publication. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [25] source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, as nucleotide sequences cannot be understood by eye, we have proposed that nucleotide sequence reagents are susceptible to different types of errors (8, 11, 12).”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Introduction
What the sources say
- Supportedcites [8] sourceExperimental — accuracy not yet measured
The section on strikingly similar gene-knockdown publications describes incorrectly identified nucleotide-sequence reagents, including reagents labeled non-targeting that were predicted to target genes. The Proposed solutions section also discusses mismatches between a sequence’s stated identity and experimental use, supporting the broad claim that these reagents can have different errors. (LLM, conf=0.86)
- Supportedcites [11] sourceExperimental — accuracy not yet measured
The “Published nucleotide sequence reagent errors” section explains that written sequences lack obvious meaning and can be transcribed incorrectly. It describes both typographic mistakes and several types of wrongly identified reagents, supporting the claim that these reagents are susceptible to different types of errors. (LLM, conf=0.94)
- Supportedcites [12] sourceExperimental — accuracy not yet measured
The Introduction says nucleotide sequences can contain different types of errors that may be hard to detect by eye, including typographic errors and wrongly identified reagents. The Results also report both error types in published reagents. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The 100 flagged C + G articles examined 13 human cancer types, where most (96/100, 96%) examined a single cancer type, typically pancreatic (35/100, 35%) or lung (22/100, 22%) cancer (Supplemental Data 3), reflecting the clinical use of cisplatin and gemcitabine (27, 28).”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > Cisplatin and gemcitabine (C + G) corpus
What the sources say
- Could not verifycites [27] sourceExperimental — accuracy not yet measured
The cited paper’s section on deriving the ERC_H_v2 test collection describes 161 papers assessed for nucleotide-sequence reagents, not a C + G corpus or its cancer-type distribution. Searches for cisplatin, gemcitabine, pancreatic cancer, and lung cancer found no passage in our copy addressing whether the cancer types reflect those drugs’ clinical use. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [28] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Most (67/115, 58%) incorrect sequences recurred across at least two SGK articles (Fig 3 and Table S1), where the most frequent incorrect reagent was a previously described “non-targeting” shRNA that is predicted to target TPD52L2 (11, 12, 13).”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > SGK corpus
What the sources say
- Partly supportedcites [11] sourceExperimental — accuracy not yet measured
The ‘Incorrect non-targeting nucleotide sequence reagents’ section identifies Sequence A as an shRNA described as ‘non-targeting’ but indicated to target TPD52L2. The ‘Additional human gene knockdown papers’ section finds Sequence A in 15 papers versus Sequence D in four. The paper does not establish that Sequence A was the most frequent incorrect reagent across the citing document’s SGK articles. (LLM, conf=0.86)
- Partly supportedcites [12] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) describes repeatedly reported “non-targeting” sequences predicted to target TPD52L2. It does not say that a TPD52L2-targeting shRNA was the most frequent incorrect reagent in SGK articles. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [13] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
134 more claims · 19 with their cited sources checked
Create a free account to see all 224 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 39
- It may state two separate claims as one. 57
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inconsistent gene nomenclature (75) and opaque numeric ncRNA and circular RNA identifiers (56,76) further add to the apparent numbers of human genes and transcripts that can be studied and combined.”
From Protection of the human gene research literature from contract cheating organizations known as research paper mills (2022) · cites this paper as [56]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reagent identities can therefore be verified by querying nucleotide or amino acid sequences against DNA/RNA or protein sequence databases, and then comparing predicted and claimed reagent identities (10, 13–15, 17).”
From Misspellings or “miscellings”—Non‐verifiable and unknown cell lines in cancer research publications (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, Byrne et al. showed that among 712 problematic papers that were cited >17,000 times, about one quarter may misinform future development of human therapies (Park et al. 2022).”
From Fake publications in biomedical science: red-flagging method indicates mass production (2026) · cites this paper as Park et al. 2022
The cited source says what the claim attributes to it.
In the citing paper
“Seek & Blastn screening supported by manual verification of reagent identities found 712 articles with wrongly identified sequences that were published across 78 journals (56).”
From Protection of the human gene research literature from contract cheating organizations known as research paper mills (2022) · cites this paper as [56]
The cited source says what the claim attributes to it.
In the citing paper
“Retrospective literature analyses (38,39,54,56), combined with qualitative research conducted with authors (35) and investigations led by publishers or journal editors (36,65,69,73), commonly suggest that human gene research is being targeted by paper mills.”
From Protection of the human gene research literature from contract cheating organizations known as research paper mills (2022) · cites this paper as [56]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Approximately half (65/128, 51%) the problematic Gene articles analysed gene function in research contexts other than human cancer, most frequently by examining gene polymorphisms in patient cohorts (16/65, 25%) (Supplemental Data 4). The remaining 60 articles analysed 17 different human cancer types”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > Analysis of Gene and Oncology Reports corpora
Reported 60 · recomputed 63
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Almost all (1,442/1,535, 94%) incorrect sequences represented targeting reagents that were claimed to target 365 protein-coding genes and 120 ncRNA’s (Table S1). The remaining 88 sequences represented incorrect “non-targeting” sequences”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > Bibliometric analysis of human genes analysed in problematic articles
Reported 88 · recomputed 93
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > SGK corpus
“| Articles from all other countries affiliated with hospitals proportion (%) | 6/15 (40%) | 0/2 (0%) | 0/6 (0%) | 0/3 (0%) | 1/10 (10%) | 0/1 (0%) |”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > SGK corpus
“| Articles from China proportion (%) | 159/174 (91%) | 73/75 (97%) | 44/50 (88%) | 31/31 (100%) | 90/100 (90%) | 50/51 (98%) |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > SGK corpus
“| SGK (n = 115 reagents in n = 75 articles) | PCRa | 0/45 (0) | 7/14 (50) | 45/57 (79) | 52/115 (45) |”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > SGK corpus
“| SGK (n = 115 reagents in n = 75 articles) | Total (Error type) | 44/44 (100) | 14/14 (100) | 57/57 (100) | 115/115 (100) |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > SGK corpus
“| Articles from China affiliated with hospitals proportion (%) | 147/159 (92%) | 68/73 (93%) | 40/44 (91%) | 28/31 (90%) | 82/90 (91%) | 48/50 (96%) |”
§ Identification of human gene research articles with wrongly identified nucleotide sequences > Results > miR-145 corpus
“All problematic miR-145 articles were published by authors from China, where almost all articles (29/31, 94%) were affiliated with hospitals”
3 more findings
Create a free account to see every finding of this check.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“10.1039/d1ra90006d”
Cited work 10.1039/d1ra90006d · retraction date not known · this paper published 2022-01-12
Citations
Cites
1 retracted
Fisher, L. (2021) · RSC Advances · doi:10.1039/d1ra90006d · Cited by 4
RetractedBasic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669 · cited 9×
“As the validation of nucleotide sequence identities using algorithms such as Blastn (28) represents a routine activity for teams that study individual genes, we hope that our results will encourage researchers to unfailingly check the identities of published nucleotide sequences, both in the context of their own resea…”
InfluentialSciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2020) · Nature Methods · doi:10.1038/s41592-019-0686-2 · Cited by 38,430
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
SciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2019) · Apollo - University of Cambridge Repository · doi:10.17863/cam.64134 · Cited by 10,460
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537 · cited 1×
“Finally, as we also noted examples of SGK and miR-145 articles that analysed the effects of drug treatments of cancer cell lines, we identified articles that described either cisplatin (29) or gemcitabine (30) treatment of human cancer cell lines and/or cancer patients as a third targeted corpus (Fig 1).”
Defining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276 · cited 1×
“Researchers can also compare the claims of gene-focussed articles with those from high-throughput experimental studies (65) and/or predictive algorithms (63, 66).”
Entrez Gene: gene-centered information at NCBI
Maglott, D., Ostell, J., Pruitt, K. D., & Tatusova, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1237 · Cited by 2,094 · cited 2×
“…of articles in PubMed that are associated with protein-coding genes in n = 709 problematic articles (Fig 7), we used the gene2pubmed service of the National Center for Biotechnology Information (31), restricting these analyses to protein-coding gene identi fi ers that mapped to of fi cial gene names.”
The support of human genetic evidence for approved drug indications
Nelson, M. R., Tipney, H., Painter, J. L., Shen, J., Nicoletti, P., Shen, Y., Floratos, A., Sham, P. C., Li, M. J., Wang, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3314 · Cited by 1,666
Research works printed but not linked: 2
- Clarivate Analytics (2019) Journal citation reports. https://jcr.clarivate.com/
- Hu, 2013, An empirical analysis on number and monetary value of ghostwritten papers in China, Curr Sci, 105, 1230
Cited by
Fake Publications in Biomedical Science: Red-flagging Method Indicates Mass Production
Sabel, B. A., Knaack, E., Gigerenzer, G., & Bilc, M. (2023) · doi:10.1101/2023.05.06.23289563 · Cited by 51
Byrne, J. A., Park, Y., Richardson, R. A. K., Pathmendra, P., Sun, M., & Stoeger, T. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1139 · Cited by 46
“Retrospective literature analyses (38,39,54,56), combined with qualitative research conducted with authors (35) and investigations led by publishers or journal editors (36,65,69,73), commonly suggest that human gene research is being targeted by paper mills.”
InfluentialSelf-citationMetadata integrity in bioinformatics: Bridging the gap between data and knowledge
Caliskan, A., Dangwal, S., & Dandekar, T. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.006 · Cited by 32
“However, Park and colleagues also analysed the articles further and predicted a high probability of 15 – 35% of these problematic publications to be cited in future clinical research, based on the concepts contained within the articles [63].”
BackgroundMethodInfluentialWittau, J., & Seifert, R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03272-8 · Cited by 36
Identifying fabricated networks within authorship-for-sale enterprises
Porter, S. J., & McIntosh, L. D. (2024) · Scientific Reports · doi:10.1038/s41598-024-71230-8 · Cited by 22
“…text that are designed to mask plagiarism [7]; the identification of common phrases and templates that appear to be used by specific paper mills [23]; the detection of manipulated images [5]; the manipulation of data [6, 42]; and, the creation of falsified data through statistical methods [3, 39].”
Metadata
- Authors
- Park, Y., West, R. A., Pathmendra, P., Favier, B., Stoeger, T., Capes-Davis, A., Cabanac, G., Labbé, C., & Byrne, J. A.
- Affiliations
- The University of Sydney (AU)
- Translational Innovation in Medicine and Complexity (FR)
- Northwestern University (US)
- Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
- Centre National de la Recherche Scientifique (FR)
- Institut polytechnique de Grenoble (FR)
- Corresponding author
- Byrne, Jennifer A
- ORCID
- Venue
- Life Science Alliance
- Publisher
- Life Science Alliance, LLC
- Published
- 2022-01-12
- Volume
- 5
- Issue
- 4
- Pages
- e202101203
- ISSN
- 2575-1077 (ISSN-L)
- PMC
- PMC8807875
- OpenAlex
- W4206098416
- Cited by
- 37
- References
- 93
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 14 · 2023: 3 · 2022: 7
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Life Science Alliance (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- US Office of Research Integrity (ORIIR180038-01-00)
- National Health and Medical Research Council of Australia (APP1184263)
- National Science Foundation (1956338)
- National Institutes on Aging (K99AG068544)
- National Institute of Allergy and Infectious Diseases (AI135964)
- Topics
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Social Sciences › Education › Academic integrity and plagiarism
- Keywords
- human protein-coding genes, non-coding RNA, research integrity, citation impact, literature screening
- MeSH terms
- Scientific Experimental Error, Human Genetics, Base Sequence, Humans, Proteins, Publications, Genome, Human, Genetic Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of human gene research articles with wrongly identified nucleotide sequences. https://app.cochat.ai/papers/10.26508/lsa.202101203
- The paper
- Park, Y., West, R. A., Pathmendra, P., Favier, B., Stoeger, T., Capes-Davis, A., Cabanac, G., Labbé, C., & Byrne, J. A. (2022). Identification of human gene research articles with wrongly identified nucleotide sequences. Life Science Alliance. https://doi.org/10.26508/lsa.202101203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.